
Overview
Signalment
Signs
Historical Findings
Physical Examination Findings
Causes & Risk Factors

Differential Diagnosis
CBC/Biochemistry/Urinalysis
Other Laboratory Tests
N/A
Imaging
Diagnostic Procedures


Drug(s)
administration due to risk of vomiting.
1050 µg/kg SC q35h for 35 days or 100 µg/kg SC q12h for 35 days; to evacuate uterus, ultrasound prior to cessation of treatment to ensure resolution of fluid accumulation in uterine lumen.Contraindications/Possible Interactions

Patient Monitoring
Possible Complications
Expected Course and Prognosis

Abbreviations
= prostaglandin F2
Suggested Reading
, . Obstetrical Emergencies II. Proceedings from the Western Veterinary Conference2012, Las Vegas, NV.
, . Periparturient diseases. In: , , eds., Canine and Feline Endocrinology and Reproduction. Philadelphia: Saunders, 2004, pp. 808834.
, , . Periparturient disorders in the bitch. In: Johnston SD, Root Kustritz MV, Olson PNS, eds., Canine and Feline Theriogenology. Philadelphia: Saunders, 2001, pp. 129145.
. Diseases of the canine uterus. Proceedings from the 7th International Symposium on Canine and Feline Reproduction, 2012, pp. 236237. Whistler, BC, Canada.
Author Joni L. Freshman
Consulting Editor Sara K. Lyle